How Inflammation Causes Atherosclerosis
Dr. Russell Blaylock, M.D., writes:
Atherosclerosis starts with inflammation in the blood vessels. When the interior lining of the vessel (called the endothelium) becomes inflamed, these cells release a substance called monocyte chemoattractant protein-1 (MCP-1) that attracts monocyte immune cells to the area. Those cells attach to the inflamed endothelial cells by releasing chemicals called vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1).
Normally, the endothelium prevents immune cells from passing through the endothelial cell layer lining the artery. But because of the tight adhesion, the monocytes can pass through the endothelial cell layer deeper into the artery.
Special: New Aging Research Reveals Key to Long, Healthy Life
Once inside, the monocytes convert to macrophages that gobble up the inflammatory fat. When this happens, the macrophages become what is called a foam cell. Unfortunately, foam cells can accumulate fat and eventually burst, releasing inflammatory fat into the deeper layer of the artery.
The macrophages also release at least two destructive enzymes called matrix metalloproteinases (MMPs), mainly MMP-2 and MMP-9. These enzymes destroy the arteries’ smooth muscle layer and form a plaque that bulges out into the internal channel of the artery (called the lumen), gradually obstructing blood flow. The body then attempts to contain the plaque buildup by forming a thick cap of fibrous tissue over it.
If this fibrous cap is successful at containing the inflamed fat (plaque), no thrombosis (formation of a blood clot) occurs. But if the fibrous cap is weak or thin, it can rupture and spill inflamed fat into the bloodstream, which can cause rapid clotting of blood that leads to either a heart attack or a stroke, depending on where in the body the artery involved is located.
The same series of events are the cause of peripheral vascular disease.